Balchem (BCPC) | Financial Analysis & Statements
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
953.7M
Gross Profit
336.2M
35.25%
Operating Income
182.9M
19.18%
Net Income
128.5M
13.47%
EPS (Diluted)
$3.93
Balance Sheet Metrics
Total Assets
1.6B
Total Liabilities
425.5M
Shareholders Equity
1.1B
Debt to Equity
0.37
Cash Flow Metrics
Operating Cash Flow
170.8M
Free Cash Flow
146.3M
Revenue & Profitability Trend
Balchem Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 953.7M | 922.4M | 942.4M | 799.0M | 703.6M |
| Cost of Goods Sold | 617.5M | 620.4M | 661.9M | 555.8M | 479.7M |
| Gross Profit | 336.2M | 302.1M | 280.5M | 243.2M | 223.9M |
| Operating Expenses | 153.3M | 142.9M | 135.3M | 115.7M | 112.8M |
| Operating Income | 182.9M | 159.2M | 145.2M | 127.5M | 111.1M |
| Pre-tax Income | 166.5M | 137.3M | 133.7M | 125.2M | 106.4M |
| Income Tax | 38.0M | 28.7M | 28.4M | 29.1M | 21.8M |
| Net Income | 128.5M | 108.5M | 105.4M | 96.1M | 84.6M |
| EPS (Diluted) | $3.93 | $3.35 | $3.25 | $2.94 | $2.60 |
Income Statement Trend
Balchem Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 313.8M | 314.2M | 335.8M | 322.2M | 266.9M |
| Non-Current Assets | 1.3B | 1.3B | 1.3B | 877.1M | 899.0M |
| Total Assets | 1.6B | 1.6B | 1.6B | 1.2B | 1.2B |
| Liabilities | |||||
| Current Liabilities | 157.7M | 148.5M | 140.0M | 143.8M | 94.4M |
| Non-Current Liabilities | 267.8M | 394.7M | 546.2M | 178.5M | 243.2M |
| Total Liabilities | 425.5M | 543.2M | 686.2M | 322.3M | 337.6M |
| Equity | |||||
| Total Shareholders Equity | 1.1B | 1.1B | 938.3M | 877.0M | 828.2M |
Balance Sheet Composition
Balchem Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 128.5M | 108.5M | 105.4M | 96.1M | 84.6M |
| Operating Cash Flow | 170.8M | 177.4M | 150.5M | 114.6M | 152.0M |
| Investing Activities | |||||
| Capital Expenditures | - | - | - | - | - |
| Investing Cash Flow | -24.1M | 3.1M | -366.1M | 2.1M | -763.0K |
| Financing Activities | |||||
| Dividends Paid | -25.6M | -22.9M | -20.7M | -18.7M | -16.7M |
| Financing Cash Flow | -151.0M | -158.6M | 243.5M | -109.1M | -200.3M |
| Free Cash Flow | 146.3M | 145.9M | 88.6M | 123.2M | 116.7M |
Cash Flow Trend
Balchem Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
39.28
Forward P/E
33.65
Price to Book
4.43
Price to Sales
5.55
PEG Ratio
33.65
Profitability Ratios
Profit Margin
14.16%
Operating Margin
20.56%
Return on Equity
11.94%
Return on Assets
7.54%
Financial Health
Current Ratio
2.44
Debt to Equity
17.21
Beta
0.92
Per Share Data
EPS (TTM)
$4.18
Book Value per Share
$37.06
Revenue per Share
$29.79
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| bcpc | 5.4B | 39.28 | 4.43 | 11.94% | 14.16% | 17.21 |
| Linde plc | 216.0B | 33.33 | 5.69 | 17.01% | 20.02% | 60.56 |
| Sherwin-Williams | 86.6B | 32.64 | 20.88 | 70.22% | 11.63% | 329.97 |
| Eastman Chemical | 9.3B | 10.24 | 1.58 | 16.03% | 9.85% | 86.00 |
| Westlake | 9.7B | 25.39 | 0.94 | 3.92% | 3.23% | 49.95 |
| Albemarle | 7.9B | 33.52 | 0.99 | -9.99% | -22.39% | 35.76 |
Financial data is updated regularly. All figures are in the company's reporting currency.